← LeaderboardsInvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Optimeos Life Sciences, Inc.
Princeton, NJ
$3,124,077
Total funding
7
Grants
Funding over time
peak $1.5M · FY2019–25$2M$1.5M$1M$500K$0
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NSF$1,981,000 · 3
NIH$1,143,077 · 4
By mechanism
—$1,981,000 · 3
R43$1,143,077 · 4
Investigators at Optimeos Life Sciences, Inc.
InvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Exposure= the full size of every grant they're on ($1M each).
Rising Stars
First grant in the last 5 yrs
Emerging Leaders
6–10 yrs in
All-Time
Most funded here, all years
Largest grants
SBIR Phase II: Formulation of a mRNA-Based Therapy for CTLN1 by Inverse Flash NanoPrecipitation$1,500,000
· FY2023 · TIP
In vivo targeted delivery of nucleic acids to hematopoietic stem cells for treating primary immunodeficiencies$300,000
R43 · FY2025 · AI
Targeted delivery of nucleic acid formulations for in vivo CAR-Treg generation$300,000
R43 · FY2024 · AI
Highly loaded long-acting depots of therapeutic peptides$287,726
R43 · FY2022 · TR
STTR Phase I: Formulation of a COVID-19 mRNA Vaccine by Inverse Flash NanoPrecipitation$256,000
· FY2020 · TIP
Sustained Release Formulations of Therapeutic Antibodies$255,351
R43 · FY2021 · GM
STTR Phase I: Sustained Delivery of Peptides with Inverse Flash Nanoprecipitation$225,000
· FY2019 · TIP